Wang et al. found in cellular experiments that fructose-2,6-bisphosphatase 4 promotes glycolysis, enhances cellular stemness, and triggers metabolic reprogramming, making hormone receptor-positive breast cancer cells resistant to palbociclib.36 This evidence concerns the gene NR4A1 and breast cancer.